A B S T R A C T Cultured skin fibroblasts were obtained from two siblings with classic clinical features of homozygous familial hypercholesterolemia. Plasma cholesterol values were 970 and 802 mg/100 ml in the siblings, 332 mg/100 ml in the mother, and 426 mg/ 100 ml in the father. Fibroblast receptor-specific capacity for binding and degradation of '25I-low density lipoprotein (LDL) at 370C was 11% of normal, consistent with the diagnosis of "homozygous LDL receptor-defective" hypercholesterolemia, a disorder in which LDL binding activity is low but detectable.
INTRODUCTION
Familial hypercholesterolemia (FH)' is associated with decreased activity of specific cell low density lipoprotein (LDL) receptors (1, 2) . The illness is most consistent with an autosomal dominant trait; persons with one abnormal gene have plasma cholesterol levels of '-350 mg/100 ml and persons with two abnormal genes have values >600 mg/100 ml (3) . The latter individuals are often termed homozygotes, but it should be recognized that the abnormal genes might not be identical or even allelic.
Homozygous hypercholesterolemia has been classified on the basis of 1251-LDL binding to skin fibroblasts (3, 4) . In most instances (60%) practically no LDL binding was seen and the patients were designated LDL receptor-negative. One patient was a genetic compound possessing one allele determining absent receptors and another determining receptors that could bind LDL but not be internalized (5) . However, -40% of homozygotes exhibited definite LDL recep-tor activity that was as much as 20 or 30% of normal and were designated LDL receptor-defective, even though no qualitative receptor abnormality was shown (3, 4, 6) . Very little is known about the receptor-defective state. The nature of the residual LDL binding has not been characterized and family studies have not been reported.
We recently studied skin fibroblasts from two LDL receptor-defective siblings with classic clinical features of homozygous FH and their heterozygous parents. LDL receptor activity was determined by the binding of 125I-LDL to the cells and analyzed to compute receptor-specific binding affinity and capacity. The results demonstrate a qualitative as well as a quantitative abnormality in LDL receptors and suggest that these apparent homozygotes are genetic compounds.
METHODS
Patients. Fasting cholesterol and triglyceride values (7) for the hypercholesterolemic siblings and their parents are shown in Table I . The children have been the subjects of previous reports (8) (9) (10) . Hypercholesterolemia (type IIA) appears in both paternal and maternal lineages as an apparent autosomal dominant trait. The father has tendon xanthomas and the older homozygote has cutaneous and tuberous xanthomas. Skin fibroblasts from the older child have been classified as LDL receptor-defective by Dr. J. Goldstein and Dr. M. Brown. LDL receptor-negative skin fibroblasts (line GM 1915 and GM 2000) were purchased from the American Type Culture Collection, Rockville, MD.
Assays. Scapular or deltoid area skin fibroblasts were explanted, cultured in Eagle's minimum essential medium (MEM) containing 15% fetal bovine serum or newborn calf serum and antibiotics, and assayed for '251-LDL binding as previously described (9, 11, 22) . Cells were plated at 105 cells/35-mm well in six-well plastic clusters. After 3-5 d the medium was removed, the cells were washed twice, and 1 ml MEM containing 10% lipoprotein-deficient human serum (LPDS) was added. After 3 d of LDL receptor induction, the medium was aspirated and replaced with 0.7 ml of the same medium containing 2.5-100 ug/ml 1251-LDL protein (20-60 cpm/ng) with and without a 10-fold or greater excess of unlabeled LDL. The cells were incubated 5 h at 37°C, the medium was removed, and the cells were placed on ice and washed. Cell-surface-bound 1251-LDL was eluted for 1 h into 10 mg/ml heparin on 4 mg/ml dextran sulfate in Puck's saline G (9, 11, 22) . The remaining cell-associated (intracellular) LDL was determined by dissolving the cells in 0.625 N NaOH. From the reaction medium noniodide 10% trichloroacetic acid soluble degradation products of '251-LDL were prepared and mixed immediately with an equal volume of 1.0 N NaOH (9) . Results are expressed as nanograms t251_ LDL/milligram cell protein±SE. All experiments were performed in triplicate wells with and without a 10-fold or greater excess of unlabeled LDL. Values presented are receptor-specific, i.e., the difference of 1251-LDL receptor activity in the absence and presence of excess unlabeled LDL. Nonspecific binding was <14% of total binding in normal cells, <28% in the FH siblings' cells, and <34% in the LDL receptor-negative homozygote cells. In experiments done at 4°C the cells were cooled 40 min before addition of MEM + 10% LPDS without bicarbonate buffered with 25 mM Hepes pH 7.3 containing 1251-LDL and incubated for 2 h. Apoprotein (apo) E was prepared from pheresis plasma very low density lipoprotein (VLDL) of an unrelated patient with type IIA hyperlipoproteinemia. Lyophilized VLDL was delipidated with 2:1 chloroform:methanol and the apo E purified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (12) . The apo E was reduced and alkylated with iodoacetamide (13) and then iodinated with Bolton-Hunter reagent (14) and exhaustively dialyzed against 0.15 M NaCl containing 10 mM tris-Cl and 1 mM EDTA, pH 7.6 (vesicle buffer). 10 mg dimyristoylphosphatidylcholine (DMPC) was dissolved in 1 ml benzene and lyophilized and, on the day of the experiment, 1 ml vesicle buffer was added and the mixture sonicated for 40 min in a water bath at room temperature with the microtip of a Fisher Scientific Co. (Pittsburgh, PA) model 300 sonic dismembrator. Such treatment yields vesicles with a distribution coefficient of 0.4 when chromatographed on Sepharose 4B (Pharmacia Fine Chemicals Inc., Piscataway, NJ). Vesicles were added to '25I-apo E in a weight ratio of 3.75:1 and incubated at room temperature 2 h. Apo E-DMPC vesicles bound to LDL receptors with Michaelis constant (Km) 0.21 gg/ml and Bmax (maximum binding capacity) 13 .1 ng/mg when assayed at 4°C as described (15) . 
RESULTS
LDL binding of the homozygotes' fibroblasts. Receptor-specific '25I-LDL processing by skin fibroblasts from FH homozygote 2 was compared with that of cells from a normal and a previously classified LDL receptor-negative homozygote. The dose-response curves shown in Fig. 1 A, C, E demonstrate that receptor-specific surface bound, internalized, and degraded '25I-LDL at saturating concentrations of 1251_ LDL was markedly reduced in both the affected cell strains. However, careful examination of the figures reveals that homozygote 2 was clearly different from the receptor-negative homozygote. At low '251-LDL concentrations (<15 ,g/ml) homozygote 2 had surface binding 69% of the normal cell strain, internalization 35% of normal, and degradation 36% of normal, whereas it was difficult to detect activity in the receptor-negative cells.
The meaning of these observations can best be appreciated from linearizing Scatchard plots ( Fig. 1 B Modification of LDL arginine residues with cyclohexanedione greatly reduces the binding of that LDL to fibroblasts (19) . As seen in Table V , modification of LDL with cyclohexanedione severely reduced the capacity to compete with 125I-LDL for receptor binding in both normal and homozygote cells.
Vesicle binding. Innerarity et al. (14) reported that semisynthetic lipoprotein particles made from apo E and DMPC (apo E-DMPC vesicles) bind with increased affinity to the LDL receptor of cultured fibroblasts. It was concluded that individual vesicles bind to multiple LDL receptors (15, 20) . We tested this unusual binding property on cells from a normal and homozygote 1 (Table VI) . At saturating amounts of lipoprotein the surface bound 1251-LDL in the homozygote cells was 24% of that of a simultaneously analyzed control. However, the surface binding of 125I1 (Table II) . When the siblings' cells were cooled to 40C before '251-LDL binding, the reduction in Km and binding capacity was greatly blunted (Table II) . When both cell types were assayed at 4°C there was no difference in the Km for 1251-LDL binding and the capacity for binding averaged 23% of normal compared with 11% of normal at 370C (Table II) . Hence, the transition in LDL binding characteristics that normally takes place on warming from 4 to 370C did not occur in the siblings' cells.
Further evidence for a qualitative LDL receptor abnormality is provided by '251-apo E-DMPC vesicle binding data (Table VI) . In both normal and homozygote 1 fewer apo E-DMPC vesicles than LDL particles bound to receptors, as expected (15) . However, the ratio of LDL particles:apo E-DMPC vesicles bound was 4 (Table V) . The molecular explanation of increased affinity and reduced capacity for LDL observed in our patients is not known, but several interpretations are possible: (a) a structural mutation or modification of the LDL receptor causes unusual receptor binding properties; (b) a defect of the cell membrane or the cytoskeleton alters receptor activity; (c) the LDL receptors are structurally normal but are aggregated such that one LDL particle binds to several receptors, thus reducing the binding capacity but increasing the binding affinity. The latter possibility is attractive because the increased affinity and reduced capacity seen in the FH siblings are very reminiscent of the binding characteristics of apo E-high density lipoprotein (HDL)C to normal fibroblasts at 37°C (20, 21) . Apo E-HDLC is an abnormal lipoprotein containing only the E apoprotein, which binds to more than one LDL receptor site, effectively cross-linking them. Affinity for apo E-HDLC is increased 22-fold, whereas binding capacity is reduced to 25% of expected, both effects are probably the result of binding to multiple receptors (15) . In our patients, aggregation of the receptors could explain the increased affinity and reduced capacity for LDL observed as well as the much greater deficiency of LDL binding than of apo E-DMPC vesicle binding (Table VI) . The latter would be expected if LDL bound to mutant receptor aggregates that could not be further cross-linked by apo E-DMPC vesicles. However, direct evidence for receptor aggregation is lacking.
Homozygous FH is usually thought to be due to inheritance of two genes specifying absent LDL receptors. In the case of the siblings the data is best explained by inheritance of two different genes, one resulting is absence of half the LDL receptors (an LDL receptornegative heterozygote) and one specifying a reduced number of qualitatively abnormal receptors. Fig. 3 demonstrates that the mother had about half the expected '25I-LDL binding but a normal Km and appeared to be a typical LDL receptor-negative heterozygote. The father had only an 18% reduction in 1251_ LDL binding and a Km reduced to 52% of -expected. Unpublished studies on two affected heterozygous members of the father's kindred show similar results. As assessed indirectly by the ability of LDL to stimulate fibroblast cholesterol esterification (Table III) , the father had much less reduction in LDL receptor function than the mother. In addition, the father's cells had a decreased ratio of '251-LDL binding at 37°:4°C as did his children (Table IV) . Despite the mild nature of the LDL binding defect, his plasma cholesterol was 426 mg/100 ml (Table I ) and tendon xanthomas were present. Likewise, the older sibling has shown no consistent lowering of plasma cholesterol despite treatment with colestipol, nicotinic acid, and sitosterol, and he appears to be as severely affected as reported LDL receptor-negative homozygotes (3). Whether or not the two hypercholesterolemia genes possessed by the siblings are allelic cannot be determined from the present data.
These results provide direct evidence for the association of clinically important hypercholesterolemia with a qualitative as well as quantitative abnormality of LDL receptors. They define the specific LDL binding characteristics of fibroblasts from one form of ".receptor-defective" FH. It is likely that this category is heterogeneous and that careful study of LDL receptor characteristics might lead to further insights as to the etiology of this illness.
